Profile data is unavailable for this security.
About the company
Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
- Revenue in USD (TTM)3.79m
- Net income in USD-118.90m
- Incorporated2010
- Employees157.00
- LocationCibus Inc6455 Nancy Ridge DriveSAN DIEGO 92121United StatesUSA
- Phone+1 (858) 450-0008
- Fax+1 (302) 636-5454
- Websitehttps://www.cibus.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Picard Medical Inc | 4.77m | -33.80m | 118.66m | 75.00 | -- | 14.89 | -- | 24.86 | -0.4673 | -0.4673 | 0.066 | 0.1081 | -- | -- | -- | 63,653.33 | -- | -- | -- | -- | -10.03 | -- | -660.85 | -- | 0.9373 | -0.7808 | 0.0134 | -- | -12.93 | -- | -31.86 | -- | -- | -- |
| Pro-Dex Inc | 70.23m | 11.19m | 121.92m | 181.00 | 11.35 | 2.99 | 9.80 | 1.74 | 3.35 | 3.35 | 21.03 | 12.73 | 1.18 | 2.65 | 4.40 | 388,016.60 | 18.87 | 12.06 | 23.88 | 15.24 | 28.09 | 29.81 | 15.94 | 11.73 | 2.14 | -- | 0.2418 | 0.00 | 23.68 | 13.84 | 322.10 | 7.99 | 19.14 | -- |
| Neuronetics Inc | 129.87m | -44.50m | 123.27m | 716.00 | -- | 4.50 | -- | 0.9492 | -0.8344 | -0.8344 | 2.24 | 0.3997 | 1.18 | 13.87 | 7.31 | 181,386.90 | -40.63 | -29.61 | -52.56 | -36.96 | 50.43 | 74.98 | -34.35 | -53.71 | 2.09 | -4.31 | 0.6768 | -- | 4.96 | 3.63 | -44.78 | -- | 12.51 | -- |
| Treace Medical Concepts Inc | 218.88m | -50.11m | 128.71m | 477.00 | -- | 1.44 | -- | 0.588 | -0.7947 | -0.7947 | 3.48 | 1.40 | 1.07 | 1.04 | 7.66 | 458,865.80 | -24.47 | -24.03 | -30.34 | -29.17 | 79.87 | 80.99 | -22.89 | -24.97 | 2.36 | -22.69 | 0.3829 | -- | 11.89 | 39.65 | -12.55 | -- | 57.11 | -- |
| Fonar Corp | 105.43m | 6.99m | 136.58m | 535.00 | 17.84 | 0.696 | 9.74 | 1.30 | 1.04 | 1.04 | 15.74 | 26.69 | 0.4897 | 22.33 | 1.28 | 197,073.50 | 4.34 | 6.77 | 4.42 | 7.19 | 41.07 | 45.46 | 8.86 | 13.74 | 8.46 | -- | 0.0021 | -- | 1.43 | 4.02 | -21.26 | 0.1719 | -12.96 | -- |
| LifeMD Inc | 252.34m | -7.71m | 140.08m | 304.00 | -- | 103.15 | 28.37 | 0.5551 | -0.1711 | -0.1711 | 5.66 | 0.0282 | 3.64 | 10.83 | 33.00 | 830,075.60 | -4.29 | -109.71 | -31.14 | -396.03 | 86.96 | 85.59 | -1.18 | -33.12 | 0.6645 | 0.3164 | 0.00 | -- | 39.27 | 76.32 | 7.23 | -- | -- | -- |
| Cibus Inc | 3.79m | -118.90m | 141.91m | 157.00 | -- | 2.18 | -- | 37.40 | -3.26 | -3.26 | 0.0972 | 0.9588 | 0.0109 | -- | 4.23 | 24,165.61 | -36.11 | -80.24 | -39.32 | -89.98 | -- | -- | -3,322.54 | -1,268.46 | -- | -2.18 | 0.8131 | -- | 134.56 | -10.19 | 6.07 | -- | -22.92 | -- |
| Citrine Global Corp | 0.00 | -1.74m | 141.93m | 18.00 | -- | -- | -- | -- | -0.0016 | -0.0016 | 0.00 | -0.0031 | 0.00 | -- | -- | 0.00 | -118.80 | -238.43 | -- | -- | -- | -- | -- | -186,483.40 | -- | -2.10 | -- | -- | -- | -- | 25.99 | -- | -- | -- |
| Anika Therapeutics Inc | 82.20m | 13.91m | 147.82m | 288.00 | 10.88 | 1.01 | 7.31 | 1.80 | 0.9419 | -2.28 | 5.70 | 10.18 | 0.3907 | 0.486 | 3.25 | 285,430.60 | 6.61 | -1.87 | 7.39 | -2.06 | 54.29 | 60.74 | 16.92 | -4.73 | 4.47 | -- | 0.00 | -- | -0.7327 | 0.9077 | -156.70 | -- | 24.14 | -- |
| LENSAR Inc | 59.14m | -51.52m | 148.35m | 140.00 | -- | -- | -- | 2.51 | -4.39 | -4.39 | 4.99 | -1.02 | 0.8946 | 1.79 | 11.51 | 422,435.70 | -77.94 | -32.69 | -121.49 | -38.95 | 46.15 | 51.51 | -87.12 | -54.77 | 0.6671 | -- | -- | -- | 26.87 | 11.87 | -118.34 | -- | -40.48 | -- |
| InfuSystem Holdings Inc | 141.05m | 5.52m | 154.76m | 502.00 | 29.09 | 2.79 | 8.17 | 1.10 | 0.2616 | 0.2616 | 6.65 | 2.73 | 1.38 | 10.25 | 5.79 | 280,984.10 | 5.41 | 4.50 | 6.56 | 5.46 | 55.35 | 55.24 | 3.92 | 3.86 | 1.60 | 7.73 | 0.274 | 0.00 | 7.22 | 10.70 | 168.92 | 11.50 | -4.62 | -- |
| Nano-X Imaging Ltd | 12.30m | -55.71m | 155.03m | 165.00 | -- | 0.9346 | -- | 12.60 | -0.8839 | -0.8839 | 0.195 | 2.40 | 0.0683 | 13.17 | 7.18 | 74,557.58 | -30.95 | -28.17 | -33.30 | -31.20 | -98.04 | -- | -452.82 | -1,072.25 | 3.93 | -- | 0.0201 | -- | 13.91 | -- | 11.95 | -- | 85.79 | -- |
| Lucid Diagnostics Inc | 4.40m | -65.84m | 157.11m | 72.00 | -- | -- | -- | 35.71 | -0.8968 | -0.8968 | 0.0526 | 0.1973 | 0.1161 | 12.24 | 14.94 | 61,097.22 | -140.60 | -139.37 | -301.55 | -297.39 | -58.13 | -- | -1,211.30 | -2,492.79 | 1.88 | -- | 0.4633 | -- | 79.00 | -- | -0.6817 | -- | -- | -- |
| CVRx Inc | 55.97m | -52.02m | 159.36m | 206.00 | -- | 3.31 | -- | 2.85 | -2.02 | -2.02 | 2.18 | 1.83 | 0.4684 | 0.7458 | 6.49 | 271,694.20 | -43.53 | -37.08 | -47.98 | -40.02 | 84.49 | 81.33 | -92.95 | -151.18 | 8.60 | -8.49 | 0.5072 | -- | 30.53 | 52.31 | -45.55 | -- | 66.61 | -- |
| Apyx Medical Inc | 47.90m | -14.54m | 160.78m | 220.00 | -- | 25.35 | -- | 3.36 | -0.3644 | -0.3644 | 1.19 | 0.1546 | 0.8113 | 1.97 | 3.68 | 217,736.40 | -24.60 | -27.67 | -29.90 | -33.35 | 62.65 | 64.81 | -30.32 | -43.61 | 3.61 | -2.04 | 0.8507 | -- | -8.11 | 11.24 | -25.38 | -- | -11.11 | -- |
| Inogen Inc | 347.03m | -25.38m | 166.42m | 766.00 | -- | 0.844 | -- | 0.4796 | -1.00 | -1.00 | 13.47 | 7.26 | 1.13 | 7.92 | 9.30 | 453,039.20 | -8.28 | -11.40 | -10.67 | -13.50 | 44.76 | 44.22 | -7.31 | -13.82 | 2.75 | -- | 0.00 | -- | 6.35 | -1.49 | 64.97 | -- | 38.15 | -- |
Data as of Feb 11 2026. Currency figures normalised to Cibus Inc's reporting currency: US Dollar USD
21.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 30 Sep 2025 | 7.34m | 13.98% |
| Vantage Consulting Group, Inc.as of 30 Sep 2025 | 1.14m | 2.18% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.07m | 2.04% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 282.15k | 0.54% |
| Certior Financial Group LLCas of 31 Dec 2025 | 271.16k | 0.52% |
| Geode Capital Management LLCas of 30 Sep 2025 | 262.71k | 0.50% |
| Prescott Group Capital Management LLCas of 31 Dec 2025 | 198.16k | 0.38% |
| Gratia Capital LLCas of 30 Sep 2025 | 167.25k | 0.32% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 161.55k | 0.31% |
| Millennium Management LLCas of 30 Sep 2025 | 147.49k | 0.28% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
